Skip to main content

GREAT POINT PARTNERS LLC

Position in NKTR — Nektar Therapeutics

CIK 1281446 Greenwich, CT

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,216,750
-$10,552,043 QoQ
Shares Held
175,000
-44.7% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
2.88%
of 13F equity value
Holder Rank
#41
of 239 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Mar 31, 2022
CallValue
$539,000
CallShares
6,667
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GREAT POINT PARTNERS LLC holds $397,271,949 across 33 Biotechnology names. NKTR ranks #15 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,216,750 175,000
2026-03-31 $22,768,793 316,453
2025-12-31 $8,909,748 210,732
2025-09-30 $17,070,000 300,000
2022-09-30 $1,433,024 447,820
2022-06-30 $11,970,000 3,150,000
2022-03-31 $539,000 100,000
2021-12-31 $2,754,689 203,900
2021-09-30 $9,064,250 504,691